Gene Profile of Adipose Tissue of Patients with Pheochromocytoma/Paraganglioma
Judita Klímová,
Miloš Mráz,
Helena Kratochvílová,
Zdeňka Lacinová,
Květoslav Novák,
David Michalský,
Jan Kvasnička,
Robert Holaj,
Denisa Haluzíková,
Radka Petráková Doležalová,
Matěj Zítek,
Zuzana Krátká,
Veronika Todorovová,
Jiří Widimský,
Martin Haluzík,
Tomáš Zelinka,
Ondřej Petrák
Affiliations
Judita Klímová
Center of Hypertension, 3rd Department of Medicine, First Faculty of Medicine and General Faculty Hospital, Charles University, 128 00 Prague, Czech Republic
Miloš Mráz
Center for Experimental Medicine and Diabetes Center, Institute for Clinical and Experimental Medicine, 140 00 Prague, Czech Republic
Helena Kratochvílová
Institute for Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine and General Faculty Hospital, Charles University, 128 00 Prague, Czech Republic
Zdeňka Lacinová
Center for Experimental Medicine and Diabetes Center, Institute for Clinical and Experimental Medicine, 140 00 Prague, Czech Republic
Květoslav Novák
Department of Urology, First Faculty of Medicine and General Faculty Hospital, Charles University, 128 00 Prague, Czech Republic
David Michalský
First Department of Surgery, First Faculty of Medicine and General Faculty Hospital, Charles University, 128 00 Prague, Czech Republic
Jan Kvasnička
Center of Hypertension, 3rd Department of Medicine, First Faculty of Medicine and General Faculty Hospital, Charles University, 128 00 Prague, Czech Republic
Robert Holaj
Center of Hypertension, 3rd Department of Medicine, First Faculty of Medicine and General Faculty Hospital, Charles University, 128 00 Prague, Czech Republic
Denisa Haluzíková
Institute of Sport Medicine, First Faculty of Medicine and General Faculty Hospital, Charles University, 128 00 Prague, Czech Republic
Radka Petráková Doležalová
Institute of Sport Medicine, First Faculty of Medicine and General Faculty Hospital, Charles University, 128 00 Prague, Czech Republic
Matěj Zítek
Center of Hypertension, 3rd Department of Medicine, First Faculty of Medicine and General Faculty Hospital, Charles University, 128 00 Prague, Czech Republic
Zuzana Krátká
Center of Hypertension, 3rd Department of Medicine, First Faculty of Medicine and General Faculty Hospital, Charles University, 128 00 Prague, Czech Republic
Veronika Todorovová
Laboratory of Endocrinology and Metabolism, 3rd Department of Medicine, First Faculty of Medicine and General Faculty Hospital, Charles University, 128 00 Prague, Czech Republic
Jiří Widimský
Center of Hypertension, 3rd Department of Medicine, First Faculty of Medicine and General Faculty Hospital, Charles University, 128 00 Prague, Czech Republic
Martin Haluzík
Center for Experimental Medicine and Diabetes Center, Institute for Clinical and Experimental Medicine, 140 00 Prague, Czech Republic
Tomáš Zelinka
Center of Hypertension, 3rd Department of Medicine, First Faculty of Medicine and General Faculty Hospital, Charles University, 128 00 Prague, Czech Republic
Ondřej Petrák
Center of Hypertension, 3rd Department of Medicine, First Faculty of Medicine and General Faculty Hospital, Charles University, 128 00 Prague, Czech Republic
Background: Brown adipose tissue (BAT) is a therapeutic target to combat obesity and related disorders. Pheochromocytoma and functional paraganglioma (PPGL) are associated with activated BAT due to catecholamine excess. Our aim was to evaluate BAT activity by gene profile and assess its relation to clinical characteristics and overproduced catecholamine. Methods: mRNA expression of 15 genes in subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) was measured via RT-PCR in 25 patients with PPGL and 14 controls undergoing cholecystectomy. Results: We found in VAT of PPGL higher expression of UCP1 (p CEBPB, PPARGC1A (both p PRDM16 (p = 0.069) and DIO2 (p = 0.005). UCP1 expression correlated only with norepinephrine levels and its metabolite. UCP1 expression, among others, correlated negatively with BMI, age and positively with HDLc levels. Dominance of BAT or BeAT markers was not assessed in PPGL. In SAT of PPGL, we found higher expression of ADRB3, CIDEA (both p PPARGC1A (p = 0.001), but not UCP1. Conclusion: We demonstrate signs of UCP1-dependent norepinephrine-induced thermogenesis connected with higher expression of DIO2, PPARGC1A, CEBPB and PRDM16 in retroperitoneal VAT of PPGL and its relations to circulating HDLc and triglycerides levels. However, no direct relationship with increased basal energy metabolism measured by calorimetry was found.